Newron Pharmaceuticals S.p.A. (SWX:NWRN)
10.82
-0.14 (-1.28%)
Sep 30, 2025, 5:31 PM CET
Newron Pharmaceuticals Revenue
Newron Pharmaceuticals had revenue of 11.90M EUR in the half year ending June 30, 2025, with 116.56% growth. This brings the company's revenue in the last twelve months to 59.88M, up 759.12% year-over-year. In the year 2024, Newron Pharmaceuticals had annual revenue of 51.39M with 467.41% growth.
Revenue (ttm)
59.88M EUR
Revenue Growth
+759.12%
P/S Ratio
3.86
Revenue / Employee
2.72M EUR
Employees
22
Market Cap
215.98M CHF
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 51.39M | 42.33M | 467.41% |
Dec 31, 2023 | 9.06M | 2.96M | 48.62% |
Dec 31, 2022 | 6.09M | 332.00K | 5.76% |
Dec 31, 2021 | 5.76M | 504.00K | 9.59% |
Dec 31, 2020 | 5.26M | -1.78M | -25.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 63.49B |
Novartis AG | 43.89B |
Lonza Group AG | 7.09B |
Galderma Group AG | 3.73B |
Alcon | 7.97B |
Sandoz Group AG | 8.42B |
Straumann Holding AG | 2.58B |
Sonova Holding AG | 3.87B |
Newron Pharmaceuticals News
- 18 days ago - Newron Pharmaceuticals S.p.A. (NWPHF) Presents at 17th World Congress of Biological Psychiatry (WCBP) - Slideshow - Seeking Alpha
- 6 months ago - Newron Pharmaceuticals reports FY results - Seeking Alpha